Cargando…
Transmucosal Buprenorphine in the Treatment of Dyspnea: Case Series and Review of the Literature
Full μ-opioid agonists are commonly employed in advanced disease to relieve dyspnea of various etiologies. Although there are ongoing debates and studies regarding the relative efficacy of different agents, a factor limiting more general use is a concern about side effects, in particular respiratory...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Mary Ann Liebert, Inc., publishers
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241374/ https://www.ncbi.nlm.nih.gov/pubmed/34223499 http://dx.doi.org/10.1089/pmr.2020.0091 |